eFFECTOR Therapeutics, Inc.: Nasdaq/NYSE listing notice — Nasdaq grants eFFECTOR Therapeutics additional 180 days to regain $1 bid price compliance

eFFECTOR Therapeutics, Inc.

Received Nasdaq letter on Feb 28, 2023, extending compliance deadline to Aug 28, 2023.
Previously had until Feb 27, 2023, to meet minimum $1.00 closing bid price requirement.
Company may pursue a reverse stock split (if stockholder-approved) to regain compliance.
If not compliant by Aug 28, 2023, Nasdaq will issue delisting notice; appeal rights exist.
No assurance of regaining compliance or maintaining other Nasdaq listing requirements.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

eFFECTOR Therapeutics, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: extension granted
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

February 28, 2023, the Company received a second letter from Nasdaq advising that the Company had been granted an additional 180 calendar days, or to August 28, 2023, to regain compliance with the Minimum Bid Requirement, in accordance with Nasdaq Listing Rule 5810(c)(3)(A). The Company intends to continue to actively monitor the closing bid price of its common stock and will evaluate available options to regain compliance with the Minimum Bid Requirement, including potentially implementing a reverse stock split of its outstanding common stock (if approved by the Company’s stockholders) to att

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001193125-23-060785

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.